Alternate Donor Study of Pre-Emptive Cellular Therapy (CMV-ACE/ASPECT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01220895 |
|
Recruitment Status :
Completed
First Posted : October 14, 2010
Last Update Posted : January 25, 2018
|
Sponsor:
Cell Medica Ltd
Collaborators:
Leukaemia Lymphoma Research
National Health Service, Blood and Transplant
University of Birmingham
Information provided by (Responsible Party):
Cell Medica Ltd
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2013 |
| Actual Study Completion Date : | January 2014 |